Showing results (1451-1460 of 1,462) with videos related to

Sort By:
Pageof 147
Circulation Research|January 4, 2019
Convergences of Life Sciences and Engineering in Understanding and Treating Heart FailureJoel L Berry, Wuqiang Zhu, Yao Liang Tang, et al.
American Journal of Human Genetics|February 1, 2011
Mutations in prickle orthologs cause seizures in flies, mice, and humansHirotaka Tao, J Robert Manak, Levi Sowers, et al.
Critical Care (London, England)|September 6, 2019
A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndromeHangyong He, Bing Sun, Lirong Liang, et al.
JAMA|May 26, 2021
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical TrialNawal Al Kaabi, Yuntao Zhang, Shengli Xia, et al.
Cell Research|January 13, 2025
Rice transcription factor bHLH25 confers resistance to multiple diseases by sensing H2O2Haicheng Liao, Yu Fang, Junjie Yin, et al.
Signal Transduction and Targeted Therapy|June 6, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trialNawal Al Kaabi, Yun Kai Yang, Jing Zhang, et al.
Nature Communications|June 27, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Signal Transduction and Targeted Therapy|January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Cell Death and Differentiation|April 26, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Pageof 147